Effect of Baladya Yamaka in Shirahshula

A comparative clinical study to evaluate the effect of Baladya Yamaka administered orally and as Navana Nasya in the management of Vatika Shirahshula with special reference to tension headache

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/05/033735

Enrollment

Registered

2021-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G442- Tension-type headache

Interventions

Intervention1: INTERVENTION- BALADYA YAMAKA THROUGH NASYA (NASAL ROUTE) ADMINISTRATION: GROUP 1- 2 COURSES OF NASYA OF BALADYA YAMAKA FOR 7 DAYS EACH WITH A GAP OF 7 DAYS IN BETWEEN. NASYA PROCEDURE-

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of both genders, between the age of 16 to 60 years. 2. Headache lasting from 30 minutes to 7 days in last 30 days with re-occurrence. 3. Patients fulfilling the diagnostic criteria. 4. Nasya Yogya for group 1 5. Headache which is pressing, tightening / stretching in nature. 6. Clinically diagnosed patients of Vatika Shirahshula (Tension headache)

Exclusion criteria

Exclusion criteria: 1. Patients known case of migraine and cluster headaches. 2. Associated with systemic disorders. 3. Patients with ENT infections. 4. Nasya Ayogya for group 1 5. Any pathology involving in eyes 6. Secondary headache arising due to meningitis, tumor, cervical spondylitis.

Design outcomes

Primary

Measure	Time frame
REDUCTION IN HEADACHETimepoint: 0TH DAY, 7TH DAY, 21ST DAY, 28H DAY, 58TH DAY	—

Secondary

Measure	Time frame
Overall improvement in quality of life (QoL)Timepoint: 0TH DAY, 7TH DAY, 21ST DAY, 28H DAY, 58TH DAY	—

Countries

India

Contacts

Public ContactDr Chanchal Aggarwal

All India Institute of Ayurveda

santoshbhatted@rediffmail.com9414048459

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026